This study is currently recruiting.

Description:  This study will monitor for potential chronic liver injury and liver fibrosis, in participants treated with cannabidiol oral solution.

Eligibility & Criteria

Eligible Age Range: 1 year and older

Gender: All

Diagnosis: Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex

Visit ClinicalTrials.gov to learn more.